ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS)

Historical Holders from Q2 2018 to Q3 2025

Symbol
ATOS on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
129M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
19.4M
Holdings value
$16.8M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
63
Number of buys
20
Number of sells
-49
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 4.51% $5.19M 5.83M The Vanguard Group 30 Jun 2025
CVI Investments, Inc. 4.3% $3.34M 5.66M CVI Investments, Inc. 31 Dec 2024
BlackRock, Inc. 1.6% $1.86M 2.09M BlackRock, Inc. 30 Jun 2025

Institutional Holders of ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 19.4M $16.8M -$1.65M $0.87 63
2025 Q2 21.3M $17.7M -$5.65M $0.83 82
2025 Q1 28.4M $19.1M -$1.34M $0.67 82
2024 Q4 29.9M $28.2M +$2.33M $0.94 83
2024 Q3 27.3M $41.6M +$1.11M $1.52 85
2024 Q2 26.2M $31.2M +$1.35M $1.19 76
2024 Q1 1.09M $1.97M -$437K $1.80 8
2023 Q4 16M $14.1M -$66.2K $0.88 46
2023 Q3 16.2M $11.9M -$5.71K $0.74 49
2023 Q2 16M $20.1M -$385K $1.26 47
2023 Q1 16.4M $11.9M -$1.06M $0.72 40
2022 Q4 17.9M $9.48M -$814K $0.53 46
2022 Q3 19M $15.8M -$3.5M $0.83 40
2022 Q2 23.2M $25.4M -$11.8M $1.09 58
2022 Q1 33.7M $42.2M -$5.24M $1.25 69
2021 Q4 39.1M $62.9M +$10.7M $1.60 79
2021 Q3 30.8M $101M -$24.7M $3.26 85
2021 Q2 35.7M $225M +$158M $6.32 83
2021 Q1 7.61M $16.1M +$10.3M $2.11 48
2020 Q4 1.56M $1.48M +$454K $0.95 10
2020 Q3 720K $1.74M +$1.02M $2.42 19
2020 Q2 298K $1.13M +$254K $3.79 8
2020 Q1 225K $299K -$74K $1.33 4
2019 Q4 287K $450K +$55.9K $1.57 10
2019 Q3 249K $488K +$3K $1.96 10
2019 Q2 241K $614K -$188K $2.55 7
2019 Q1 190K $666K -$602K $3.50 7
2018 Q4 781K $797K +$220K $1.02 12
2018 Q3 566K $990K +$232K $1.74 7
2018 Q2 535K $1.18M +$1.18M $2.19 9